Knock-In Reporter Cell Lines for Regulatory Readouts

The first two support regulatory claims; the third is for comparison across elements; the fourth is for triage.

The signal window and CV are the numbers that determine whether a line can resolve your effect; they are reported for every line rather than on request.

• • Linker choice. P2A keeps stoichiometry; direct fusion risks misfolding for secreted or membrane proteins.
• • Insertion site within the gene. Terminal exons are safer; internal insertions can disrupt domains.
• • Allele handling. In heterozygous backgrounds, decide deliberately whether monoallelic readout is acceptable, and state it.
• • Promoter for landing pads. A minimal promoter reduces background but also reduces dynamic range.
• • Selection strategy. Antibiotic selection during cloning, then withdrawal, to avoid confounding the readout.

Endogenous knock-ins at difficult loci, and iPSC backgrounds, move to the upper end.

Can you knock a reporter into a gene with multiple isoforms?Yes, but the insertion site must be chosen so that the tag is present in the isoforms you care about. We report which isoforms carry the reporter.

How large a payload can be integrated?Fluorescent proteins and HiBiT are routine; larger cassettes reduce HDR efficiency and usually require a selection marker, which we then remove or silence before delivery.

Do you provide the parental line as a control?Yes — the matched parental or non-targeting clone from the same campaign, which is the comparison that makes the signal interpretable.

Send the element or gene, the cell type, and the effect size you need to resolve. We will recommend an architecture and state the signal window that architecture can deliver before you commit.

Contact EDITGENE to request a project consultation or quote.

Reporter activity is a proxy for the endogenous event; where a claim depends on native context, an endogenous knock-in is required.

Signal window and variability are cell-type- and locus-specific and are measured per line rather than assumed.

• • Schwinn MK, et al. CRISPR-mediated tagging of endogenous proteins with a luminescent peptide. ACS Chemical Biology. 2018;13:467–474.
• • Sadelain M, et al. Safe harbours for the integration of new DNA in the human genome. Nature Reviews Cancer. 2011;12:51–58.
• • Inoue F, Ahituv N. Decoding enhancers using massively parallel reporter assays. Genomics. 2015;106:159–164.